A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma. - Turner KA; Edwards CC; Ketch PW; Dinkins KG; Wilbanks A; Leath CA 3rd; Arend RC; Toboni MD (Gynecologic oncology, 2026)